CRN has taken the preliminary position that cooperative international development of molecular manufacturing (MM) capability is the safest course to avoid an unstable arms race and/or extreme economic upheaval, while providing the greatest benefits to the greatest number.
However, this course is by no means guaranteed. It appears more likely that the United States or some other nation (or bloc of nations) will achieve MM through independent programs.
Assuming that a push for international development does not succeed, would unilateral development by the U.S. be the next best option? Or would development by some other entity (India? China? Russia?) be more likely to avoid the gravest dangers? Who should get it first?
CRN welcomes your serious consideration of these questions and requests your input in our process of deliberation and policy recommendation.